Clinical Trial

Oxytocin in Postmenopausal Women

Study acronym: OxyMENO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the present study is to assess whether cumulative endogenous neurophysin I secretion over one month differs between premenopausal and postmenopausal women. Using repeated measurements of neurophysin-I (NP-I, equimolar surrogate marker of oxytocin) across defined physiological time points, this study investigates oxytocin system regulation under cyclic and non-cyclic hormonal conditions. The primary hypothesis is that cumulative NP-I release, expressed as the area under the curve (AUC) is lower in the postmenopausal group compared to the premenopausal group.
Trial Details
NCT Number NCT07742124
Lead Sponsor University Hospital, Basel, Switzerland
Conditions Postmenopausal, Premenopausal
Enrollment 30 participants
Start Date 2027-06-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-03